Clinical Trial Update: Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide

View source ↗

Summary

A completed AstraZeneca-sponsored trial reports on patient compliance with treatment regimens using candesartan or candesartan/hydrochlorothiazide for essential…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Candesartan (candesartan)
• Candesartan/Hydrochlorothiazide (candesartan/hydrochlorothiazide)

Snippet

Sponsor: AstraZeneca | Conditions: Essential Hypertension | Status: COMPLETED